Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Cost-Effectiveness of Interventional Therapies for Management of Treatment-Resistant Hypertension: Systematic Review of Pharmacoeconomic Studies
Shekoufeh Nikfar
Shekoufeh Nikfar

Professor of Pharmacoeconomics and Pharmaceutical Administration

Department Pharmacoeconomics and Pharmaceutical Administration

School of Pharmacy

Pharmaceutical Management & Economics Research Center

Tehran University of Medical Sciences

All Documents
1. Advancements in Pharmacotherapy Options for Treating Diabetes ‎In Children and Adolescents, Expert Review of Endocrinology and Metabolism (2024)
2. Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple Sclerosis, Value in Health Regional Issues (2024)
3. Drugs of the Future for Diarrhea-Predominant Irritable Bowel Syndrome: An Overview of Current Investigational Drugs, Expert Opinion on Investigational Drugs (2024)
4. Pharmacokinetic Considerations for Drugs That Treat Diarrhea-Predominant Irritable Bowel Syndrome: What’S New?, Expert Opinion on Drug Metabolism and Toxicology (2024)
5. Systematic Review of Patient Preference Studies in Non-Metastatic Breast Cancer Adjuvant Medication Therapy: Attribute Selection, Iranian Journal of Pharmaceutical Research (2024)
6. Towards Greater Impact in Health Technology Assessment: System Dynamic Approach for New and Emerging Technologies in Iran, DARU# Journal of Pharmaceutical Sciences (2024)
7. A Cost-Effectiveness Analysis of Linagliptin Add-On to Insulin Treatment for Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease in Iran, Journal of Diabetes and Metabolic Disorders (2023)
8. An Update on the Use of Pharmacotherapy for Opioid-Induced Bowel Dysfunction, Expert Opinion on Pharmacotherapy (2023)
9. An Updated Systematic Review and Dose-Response Meta-Analysis on the Relation Between Exposure to Arsenic and Risk of Type 2 Diabetes, Toxicology Letters (2023)
10. Common Gastrointestinal Drug-Drug Interactions in Geriatrics and the Importance of Careful Planning, Expert Opinion on Drug Metabolism and Toxicology (2023)
11. Cost-Effectiveness and Budget Impact Analysis of Lisdexamfetamine Versus Methylphenidate for Patients Under 18 With Attention-Deficit/Hyperactivity Disorder in Iran, Child and Adolescent Psychiatry and Mental Health (2023)
12. Cost-Effectiveness Comparison Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran, Journal of Tehran University Heart Center (2023)
13. European Union and Its European Commission, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
14. Hair, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
15. How Do Patients Value Features of Biological Medicine in Rheumatoid Arthritis? a Discrete Choice Experiment, Expert Review of Pharmacoeconomics and Outcomes Research (2023)
16. Occupational Exposure Limits, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
17. Organization for Economic Cooperation and Development (Oecd), Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
18. Pharmacoeconomic Evaluation of Insulin Aspart and Glargine in Type 1 and 2 Diabetes Mellitus in Iran, Journal of Diabetes and Metabolic Disorders (2023)
19. Pharmacogenetics and Toxicology, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
20. Pharmacotherapy for Gastric and Intestinal Cramping Pain: ‎ Current and Emerging Therapies, Expert Opinion on Pharmacotherapy (2023)
21. Resource Conservation and Recovery Act (Usa), Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
22. Safety Testing, Clinical Studies, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
23. Upfront Dpyd Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis, Value in Health Regional Issues (2023)
24. A Conceptual Model on the Pharmacogenomics Implementation Complications: An Applied Qualitative Research Based on National Drug Policy Components, Koomesh (2022)
25. A Review on Precision Medicine and Conducting Pharmacogenetics Tests of Drugs, Koomesh (2022)
26. A Scoping Review on Patient Heterogeneity in Economic Evaluations of Precision Medicine Based on Basket Trials, Expert Review of Pharmacoeconomics and Outcomes Research (2022)
27. Clinical Application of Gut Microbiota Metabolites: A Novel Opportunity in Personalized Medicine, Koomesh (2022)
28. Economic Aspects in Precision Medicine and Pharmacogenomics, Precision Medicine in Clinical Practice (2022)
29. Perspectives of Personalized Medicine in Traditional Persian Medicine, Koomesh (2022)
30. Pharmacogenomics Approach in Psychiatry Disorders, Koomesh (2022)
31. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing, International Journal of Molecular Sciences (2022)
32. Precision Medicine Journey Through Omics Approach, Journal of Diabetes and Metabolic Disorders (2022)
33. Role of Genetic Polymorphisms in Recurrent Aphthous Stomatitis: A Systematic Review and Meta-Analysis, Cytokine (2022)
34. Role of Personalized Medicine in Cardiovascular Disease: A Narrative Review, Koomesh (2022)
35. The Importance of Personalized Medicine in Urological Cancers, Koomesh (2022)
36. The Pharmacotherapeutic Management of Duodenal and Gastric Ulcers, Expert Opinion on Pharmacotherapy (2022)
37. Therapeutic Effects of Dietary Antioxidative Supplements on the Management of Type 2 Diabetes and Its Complications; Umbrella Review of Observational/Trials Meta-Analysis Studies, Journal of Diabetes and Metabolic Disorders (2022)
38. A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development, Medical Journal of the Islamic Republic of Iran (2021)
39. A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines, Mediterranean Journal of Rheumatology (2021)
40. A Systematic Review of Mirnas As Biomarkers in Osteoporosis Disease, Journal of Diabetes and Metabolic Disorders (2021)
41. Achieving Equitable Access to Medicines and Health Services: A Covid-19-Time Recalled Matter, Iranian Journal of Pharmaceutical Research (2021)
42. An Assessment of Trends in the Iranian Pharmaceutical Market Following Domestic Production of Selected Medications (2007‒2017) and New Considerations for Health Policymakers, GaBI Journal (2021)
43. Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type Ii Diabetes: Current Clinical Evidence and Future Perspectives, Evidence-based Complementary and Alternative Medicine (2021)
44. Cladribine Tablets Are a Cost-Effective Strategy in High-Disease Activity Relapsing Multiple Sclerosis Patients in Iran, Current Journal of Neurology (2021)
45. Comprehensive Study on the Administrative, Economic, Regional, and Regulatory Prospects of Complementary and Alternative Medicine (Cam) in Inflammatory Bowel Disease (Ibd), Expert Review of Clinical Pharmacology (2021)
46. Conducting Economic Evaluation Based on Basket Clinical Trial in the Area of Precision Medicine, Expert Review of Pharmacoeconomics and Outcomes Research (2021)
47. Cost-Effectiveness of Ocrelizumab for Treatment of Iranian Patients With Relapsing Multiple Sclerosis, Current Journal of Neurology (2021)
48. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
49. Crossing the Way of Precision Medicine Approach in Personalized Medicine Research Center: A Systematic Review, Iranian Journal of Diabetes and Metabolism (2021)
50. Drug Repurposing for the Management of Depression: Where Do We Stand Currently?, Life (2021)
51. Effect of Antihypertensive Drugs on Cognition and Behavioral Symptoms of Patients With Alzheimer's Disease: A Meta-Analysis, Current pharmaceutical biotechnology (2021)
52. Influential Factors on Pharmacist Profession-Related Errors: A Community Pharmacy Approach, Iranian Journal of Pharmaceutical Sciences (2021)
53. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
54. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
55. Pharmacogenomics Implementation and Hurdles to Overcome; in the Context of a Developing Country, Iranian Journal of Pharmaceutical Research (2021)
56. Precision Medicine Path at Personalized Medicine Research Center/Endocrinology and Metabolism Research Institute: A Systematic Review, Journal of Diabetes and Metabolic Disorders (2021)
57. Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran, Pharmaceutical Sciences (2021)
58. The Importance of Personalized Medicine in Urological Cancers, Journal of Diabetes and Metabolic Disorders (2021)
59. The Trend of Scientific Productions on the Use of Herbal Medicines in Metabolic Disorders in the Middle East Countries, Jundishapur Journal of Natural Pharmaceutical Products (2021)
60. A Brief Overview on the Use of Probiotics to Treat Overweight and Obese Patients, Expert Review of Endocrinology and Metabolism (2020)
61. A Narrative Review of Current Trends in Liraglutide: Insights Into the Unmet Needs in Management of Type 2 Diabetes and Obesity, Journal of Diabetes and Metabolic Disorders (2020)
62. A Review on Inputs and Outputs in Determining the Efficiency of Universities of Medical Sciences by Data Envelopment Analysis Method, Medical Journal of the Islamic Republic of Iran (2020)
63. A Systematic Review and Meta-Analysis of the Safety and Effectiveness of Tenecteplase Versus Alteplase in Treatment of Patients With St-Elevation Myocardial Infarction, Journal of Advances in Medical and Biomedical Research (2020)
64. An Overview of Interventions for Constipation in Adults, Expert Review of Gastroenterology and Hepatology (2020)
65. An Update on Efficacy and Safety Considerations for the Latest Drugs Used to Treat Irritable Bowel Syndrome, Expert Opinion on Drug Metabolism and Toxicology (2020)
66. Antibiotic Resistance Propagation Through Probiotics, Expert Opinion on Drug Metabolism and Toxicology (2020)
67. Atazanavir / Ritonavir Versus Lopinavir / Ritonavir-Based Combined Antiretroviral Therapy (Cart) for Hiv-1 Infection: A Systematic Review and Meta-Analysis, African Health Sciences (2020)
68. Cost-Effectiveness of Interventional Therapies for Management of Treatment-Resistant Hypertension: Systematic Review of Pharmacoeconomic Studies, Journal of Pharmaceutical Health Services Research (2020)
69. Cost-Effectiveness of Interventional Therapies for Management of Treatment-Resistant Hypertension: Systematic Review of Pharmacoeconomic Studies, Journal of Pharmaceutical Health Services Research (2020)
70. Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the Icepop Capability Measure for Adults Capability Measure in the Iranian General Population, Value in Health Regional Issues (2020)
71. Drug Discovery Strategies for Modulating Oxidative Stress in Gastrointestinal Disorders, Expert Opinion on Drug Discovery (2020)
72. Effect of the Herbal Medicines in Obesity and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials, Phytotherapy Research (2020)
73. Effects of Genistein on Blood Pressure: A Systematic Review and Meta-Analysis, Food Research International (2020)
74. Effects of Genistein on Blood Pressure: A Systematic Review and Meta-Analysis, Food Research International (2020)
75. Evaluating Naloxegol for the Treatment of Opioid-Induced Constipation, Expert Opinion on Pharmacotherapy (2020)
76. Iran, Information Resources in Toxicology# Volume 2: The Global Arena (2020)
77. Potential Vaccines for Treating Crohn's Disease, Iranian Biomedical Journal (2020)
78. Short and Long Term Impacts of Covid-19 on the Pharmaceutical Sector, DARU# Journal of Pharmaceutical Sciences (2020)
79. The Antidiabetic and Antilipidemic Effects of Hibiscus Sabdariffa: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Food Research International (2020)
80. The Antidiabetic Effect of Thymoquinone: A Systematic Review and Meta-Analysis of Animal Studies, Food Research International (2020)
81. The Efficacy and Safety of Oral Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Current Journal of Neurology (2020)
82. The Impact of Health System Reform Plan on the Cost of Inpatient Prescriptions of Health Insurance in Public Hospitals in Sari, Iran, Journal of Mazandaran University of Medical Sciences (2020)
83. The Pharmacological Management of Constipation in Patients With Parkinson’S Disease: A Much-Needed Relief, Expert Opinion on Pharmacotherapy (2020)
84. An Overview of the Efficacy and Safety of Prucalopride for the Treatment of Chronic Idiopathic Constipation, Expert Opinion on Pharmacotherapy (2019)
85. Antidiabetic Effect of Quercetin: A Systematic Review and Meta-Analysis of Animal Studies, Food and Chemical Toxicology (2019)
86. Budget Impact Analysis of Rotavirus Vaccine Adoption in the Childhood Immunization Schedule of Iran, Value in Health Regional Issues (2019)
87. Correction To: Dietary Antioxidative Supplements and Diabetic Retinopathy; a Systematic Review (Journal of Diabetes & Metabolic Disorders, (2019), 18, 2, (705-716), 10.1007/S40200-019-00434-X), Journal of Diabetes and Metabolic Disorders (2019)
88. Dietary Antioxidative Supplements and Diabetic Retinopathy; a Systematic Review, Journal of Diabetes and Metabolic Disorders (2019)
89. Effects of Alpha Lipoic Acid and Its Derivative “Andrographolid-Lipoic Acid-1” on Ulcerative Colitis: A Systematic Review With Meta-Analysis of Animal Studies, Journal of Cellular Biochemistry (2019)
90. Estimating the Cost of Illness of Prostate Cancer in Iran, Clinical Therapeutics (2019)
91. How Can We Develop Better Antispasmodics for Irritable Bowel Syndrome?, Expert Opinion on Drug Discovery (2019)
92. Is There an Appropriate Strategy for Treating Co-Morbid Irritable Bowel Syndrome and Bladder Pain Syndrome?, Expert Opinion on Pharmacotherapy (2019)
93. Patient and Physician Preferences for Type 2 Diabetes Medications: A Systematic Review, Journal of Diabetes and Metabolic Disorders (2019)
94. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
95. Precision Medicine in Non Communicable Diseases, International Journal of Molecular and Cellular Medicine (2019)
96. Providing a Framework for Assessment of the Access to Medicine, DARU# Journal of Pharmaceutical Sciences (2019)
97. Reappraisal of Probiotics’ Safety in Human, Food and Chemical Toxicology (2019)
98. The Efficacy of Standard Versus Accelerated Epi-Off Corneal Cross-Linking Protocols: A Systematic Review and Sub-Group Analysis, International Ophthalmology (2019)
99. Assessment of Frequency and Causes of Medication Errors in Pediatrics and Emergency Wards of Teaching Hospitals Affiliated to Tehran University of Medical Sciences (24 Hospitals), Journal of medicine and life (2018)
100. Comparison of the Cost-Utility Analysis of Electroacupuncture and Nonsteroidal Antiinflammatory Drugs in the Treatment of Chronic Low Back Pain, JAMS Journal of Acupuncture and Meridian Studies (2018)
101. Cost-Analysis of Treatment of Childhood Acute Lymphoblastic Leukemia Based on Ukall Protocol, Iranian Journal of Pediatrics (2018)
102. Cost-Utility of Protocols of Bfm-All and Uk-All for Treatment of Children With Acute Lymphoblastic Leukemia in Iran, Iranian Journal of Public Health (2018)
103. Effect of Resveratrol on Cognitive and Memory Performance and Mood: A Meta-Analysis of 225 Patients, Pharmacological Research (2018)
104. Effectiveness of Tenecteplase Versus Streptokinase in Treatment of Acute Myocardial Infarction: A Meta-Analysis, Tehran University Medical Journal (2018)
105. Effectiveness of Tenecteplase Versus Streptokinase in Treatment of Acute Myocardial Infarction: A Meta-Analysis, Tehran University Medical Journal (2018)
106. Efficacy and Safety of Interleukin-1 Antagonists in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis, Rheumatology International (2018)
107. Investigational Opioid Antagonists for Treating Opioid-Induced Bowel Dysfunction, Expert Opinion on Investigational Drugs (2018)
108. Methylnaltrexone Bromide for the Treatment of Opioid-Induced Constipation, Expert Opinion on Pharmacotherapy (2018)
109. Mitogen-Activated Protein Kinase (Mek) Inhibitors to Treat Melanoma Alone or in Combination With Other Kinase Inhibitors, Expert Opinion on Drug Metabolism and Toxicology (2018)
110. Pattern of Antidepressant Utilization and Cost in Iran From 2006 to 2013 in Comparison With Other Countries, Journal of Epidemiology and Global Health (2018)
111. Resveratrol and Cognitive Performance, Pharmacological Research (2018)
112. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
113. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
114. Therapeutic Effects of Oral Liothyronine on Aluminum Phosphide Poisoning As an Adjuvant Therapy: A Clinical Trial, Human and Experimental Toxicology (2018)
115. Budget Impact Analysis of Vaccination Against Haemophilus Influenzae Type B As a Part of a Pentavalent Vaccine in the Childhood Immunization Schedule of Iran, DARU# Journal of Pharmaceutical Sciences (2017)
116. Comparative Safety and Efficacy of Tyrosine Kinase Inhibitors (Tkis) in the Treatment Setting of Different Types of Leukemia, and Different Types of Adenocarcinoma, Biomedicine and Pharmacotherapy (2017)
117. Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients With Painful Bone Metastases: An Iranian Patient's Perspective Study, Value in Health Regional Issues (2017)
118. Does Evolocumab, As a Pcsk9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? a Meta-Analysis of Randomized Controlled Trials, Journal of Pharmacy and Pharmaceutical Sciences (2017)
119. Linagliptin Versus Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Clinical Trials, DARU# Journal of Pharmaceutical Sciences (2017)
120. Social Accounting Matrix and the Effects of Economic Reform on Health Price Index and Household Expenditures: Evidence From Iran, Medical Journal of the Islamic Republic of Iran (2017)
121. A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection, Iranian Red Crescent Medical Journal (2016)
122. A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With Hbeag-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model, Hepatitis Monthly (2016)
123. A Systematic Review of the Uterine Relaxant Effect of Herbal Sources, Current Pharmaceutical Biotechnology (2016)
124. Challenges of Access to Medicine and the Responsibility of Pharmaceutical Companies: A Legal Perspective, DARU# Journal of Pharmaceutical Sciences (2016)
125. Comparative Study of Direct Patient and Drug Costs Before and After the Implication of Healthcare Reform Program in Sari, Iran, Journal of Mazandaran University of Medical Sciences (2016)
126. Cost-Analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia Based on All-Bfm Protocol, International Journal of Pediatrics (2016)
127. Cost-Effectiveness Analysis of Tocilizumab in Comparison With Infliximab in Iranian Rheumatoid Arthritis Patients With Inadequate Response to Tdmards: A Multistage Markov Model, Value in Health Regional Issues (2016)
128. Drugs for the Treatment of Pediatric Type 2 Diabetes Mellitus and Related Co-Morbidities, Expert Opinion on Pharmacotherapy (2016)
129. Is Taurolidine-Citrate an Effective and Cost-Effective Hemodialysis Catheter Lock Solution? a Systematic Review and Cost- Effectiveness Analysis, Medical Journal of the Islamic Republic of Iran (2016)
130. Rituximab As First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on a Systematic Review and Meta-Analysis, Rheumatology International (2016)
131. Treatment Costs for Pediatrics Acute Lymphoblastic Leukemia; Comparing Clinical Expenditures in Developed and Developing Countries: A Review Article, International Journal of Pediatrics (2016)
132. Wealth-Related Inequality in Utilization of Antihypertensive Medicines in Iran: An Ecological Study on Population Level Data, Archives of Iranian Medicine (2016)
133. A Comprehensive Review of Clinical Trials on Egfr Inhibitors Such As Cetuximab and Panitumumab As Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer, Avicenna Journal of Medical Biotechnology (2015)
134. A Systematic Review of Drugs in Late-Stage Development for the Treatment of Multiple Sclerosis: A Focus on Oral Synthetic Drugs, Inflammation and Allergy - Drug Targets (2015)
135. Antioxidant Therapy in Acute, Chronic and Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Systematic Review and Meta-Analysis, World Journal of Gastroenterology (2015)
136. Consistent Defined Threshold and Equity in Health, DARU# Journal of Pharmaceutical Sciences (2015)
137. Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran, Hepatitis Monthly (2015)
138. Effectiveness of Probiotics in Irritable Bowel Syndrome: Updated Systematic Review With Meta-Analysis, World Journal of Gastroenterology (2015)
139. Inflammatory Bowel Disease Therapies Discontinued Between 2009 and 2014, Expert Opinion on Investigational Drugs (2015)
140. Interventions for Preventing Osteoporosis in Women on Heparin Therapy During Pregnancy, Cochrane Database of Systematic Reviews (2015)
141. Nivolumab and Pembrolizumab As Immune-Modulating Monoclonal Antibodies Targeting the Pd-1 Receptor to Treat Melanoma, Expert Review of Anticancer Therapy (2015)
142. Pregnancy Outcomes in Women With Inflammatory Bowel Disease Following Exposure to Thiopurines and Antitumor Necrosis Factor Drugs: A Systematic Review With Meta-Analysis, Human and Experimental Toxicology (2015)
143. Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration, Expert Opinion on Biological Therapy (2015)